Germline variation and risk of immune-related adverse events (irAEs): A real-world BioVU study

被引：0
|
作者：
Balko, Justin M.
Yao, Lydia
Zhang, Siwei
Fahey, Catherine
Haugh, Alexandra
Davis, Andrea
Mukherjee, Eric
Hammer, Christian
Phillips, Elizabeth J.
Bejan, Cosmin A.
Xu, Yaomin
Johnson, Douglas Buckner
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] UCSF Hem, Onc Fellowship, San Francisco, CA USA
[3] Univ Colorado, Denver, CO USA
[4] Genentech Inc, South San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10582
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Delayed immune-related adverse events profile associated with immune checkpoint inhibitors: a real-world analysis
    Yang, Yana
    Li, Linman
    Tian, Jing
    Ma, Linwen
    Wu, Yaoxin
    Luo, Qian
    Luo, Yan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [22] Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management
    Javaid, Anadil
    Bennett, Catherine
    Rao, Aparna
    Spain, Lavinia
    PHARMACEUTICAL MEDICINE, 2024, 38 (01) : 25 - 38
  • [23] Rare Immune-Related Adverse Events (irAEs): Approach to Diagnosis and Management
    Anadil Javaid
    Catherine Bennett
    Aparna Rao
    Lavinia Spain
    Pharmaceutical Medicine, 2024, 38 : 25 - 38
  • [24] Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls
    Eli P. Darnell
    Meghan J. Mooradian
    Erez N. Baruch
    Melis Yilmaz
    Kerry L. Reynolds
    Current Oncology Reports, 2020, 22
  • [25] Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls
    Darnell, Eli P.
    Mooradian, Meghan J.
    Baruch, Erez N.
    Yilmaz, Melis
    Reynolds, Kerry L.
    CURRENT ONCOLOGY REPORTS, 2020, 22 (04)
  • [26] Focus on immune-related adverse events (irAEs) in immunotherapy of hepatobiliary malignancies
    Zhang, Lei
    Zhao, Haitao
    HEPATOBILIARY SURGERY AND NUTRITION, 2020, 9 (03) : 348 - 349
  • [27] Real world outcomes of immune-related adverse events (irAEs) among patients receiving immune checkpoint inhibitors (ICIs) in hospital settings
    George, S.
    Zheng, Y.
    Kim, R.
    Yu, T.
    Dreyfus, J.
    Gayle, J. A.
    Wassel, C.
    Phatak, H.
    ANNALS OF ONCOLOGY, 2019, 30 : 522 - 522
  • [28] Real-world incidences and risk factors of immune-related adverse events in patients treated with immune checkpoint inhibitors: A nationwide retrospective cohort study
    Kim, Yong Joon
    Lee, Myeongjee
    Kim, Eun Hwa
    Lee, Seulkee
    Park, Sejung
    Shin, Sang Joon
    Jung, Inkyung
    Lee, Choong-kun
    CANCER LETTERS, 2024, 596
  • [29] Immune-Related Adverse Events Associated with Atezolizumab: Insights from Real-World Pharmacovigilance Data
    Frey, Connor
    Etminan, Mahyar
    ANTIBODIES, 2024, 13 (03)
  • [30] Real-world insights into immune-related adverse events (irAE) in gastrointestinal (GI) malignancies.
    Manne, Ashish
    Paul, Samuel
    Min, Eric
    Malalur, Pannaga
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 545 - 545
12345